InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Knowles Julius, Director. Officer active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 14 reports have been published. Breakdown: 1 buy · 11 sells. Total volume traded: €2.8m. Activity tracked since 3 May 2021. The latest transaction was filed on 21 November 2025 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Knowles Julius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
191,527 shares@ US$17.7551.0% of flowCommon StockSEC:0001808365-25-000005:0
5,250 shares0Common StockSEC:0001415889-25-015979:0
1,191 shares@ US$20.980.4% of flowCommon StockSEC:0001209191-23-004279:0
Canonical exit: 12 Jul 2020 (T+90)
3,678 shares@ US$56.820.030% mcap3.4% of flowCommon StockSEC:0001209191-22-001990:0
4,243 shares@ US$53.480.032% mcap3.7% of flowCommon StockSEC:0001209191-21-067877:0
7,057 shares@ US$41.850.041% mcap4.8% of flowCommon StockSEC:0001209191-21-062812:0
2,029 shares@ US$38.051.1% of flowCommon StockSEC:0001209191-21-061256:0
2,653 shares@ US$40.131.6% of flowCommon StockSEC:0001209191-21-060784:0
3,827 shares@ US$40.162.3% of flowCommon StockSEC:0001209191-21-059749:0
27,373 shares@ US$40.5116.4% of flowCommon StockSEC:0001209191-21-058061:0
13,268 shares@ US$41.228.0% of flowCommon StockSEC:0001209191-21-045620:0
2,988 shares@ US$47.232.0% of flowCommon StockSEC:0001209191-21-038917:0
2,309 shares@ US$51.901.7% of flowCommon StockSEC:0001209191-21-037974:0
5,383 shares@ US$56.044.3% of flowCommon StockSEC:0001209191-21-030410:0
14 of 14 declarations
About Knowles Julius
Knowles Julius is a director at Keros Therapeutics, Inc.
